The University of Chicago Header Logo

Phase I study of PM02734: Association of dose-limiting hepatotoxicity with plasma concentrations.

Phase I study of PM02734: Association of dose-limiting hepatotoxicity with plasma concentrations. J Clin Oncol. 2008 May 20; 26(15_suppl):2513.

View in: PubMed